Assyro AI

FDA Orange Book · active-ingredient family

Finasteride; tadalafil

Finasteride; tadalafil is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:ENTADFI · NDA 215423

1

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
ENTADFIRLDBLUE WATER BIOTECHNDA 215423Dec 09, 2021

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
FINASTERIDE AND TADALAFILNOVITIUM PHARMAANDA 218499Mar 19, 2025
FINASTERIDE AND TADALAFILZYDUS LIFESCIENCESANDA 218232Mar 15, 2024

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Finasteride; tadalafil — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.